🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Thomas Flaten

Stock Analyst at Lake Street

(3.21)
# 2,547
Out of 5,184 analysts
314
Total ratings
44.6%
Success rate
2.1%
Average return

Stocks Rated by Thomas Flaten

Insight Molecular Diagnostics
Nov 20, 2026
Reiterated: Buy
Price Target: $12 → $9
Current: $1.97
Upside: +356.85%
Aytu BioPharma
Nov 17, 2026
Downgraded: Hold
Price Target: $7 → $2.7
Current: $2.66
Upside: +1.50%
Rapid Micro Biosystems
Nov 16, 2026
Downgraded: Hold
Price Target: $7 → $0.75
Current: $0.735
Upside: +2.04%
Biodesix
Nov 6, 2026
Reiterated: Buy
Price Target: $40 → $30
Current: $7.56
Upside: +296.83%
MDxHealth
Oct 16, 2026
Downgraded: Hold
Price Target: $5 → $0.5
Current: $0.1074
Upside: +365.55%
Pelthos Therapeutics
Oct 12, 2026
Reiterated: Buy
Price Target: $50 → $40
Current: $6.38
Upside: +526.96%
Alterity Therapeutics
Oct 5, 2026
Reiterated: Buy
Price Target: $10
Current: $1.52
Upside: +557.89%
Harrow
Oct 5, 2026
Reiterated: Buy
Price Target: $60
Current: $30.41
Upside: +97.30%
AEON Biopharma
Oct 1, 2026
Reiterated: Buy
Price Target: $1 → $2
Current: $0.123
Upside: +1,526.02%
Connect Biopharma Holdings
Oct 1, 2026
Reiterated: Buy
Price Target: $9
Current: $0.59
Upside: +1,425.42%
Reiterated: Buy
Price Target: $57
Current: $32.86
Upside: +73.46%
Reiterated: Buy
Price Target: $9
Current: $2.74
Upside: +228.47%
Initiated Coverage: Buy
Price Target: $20
Current: $3.28
Upside: +509.76%
Reiterated: Buy
Price Target: $6
Current: $3.46
Upside: +73.41%
Reiterated: Buy
Price Target: $9
Current: $2.25
Upside: +300.00%
Reiterated: Hold
Price Target: $16
Current: $14.27
Upside: +13.88%
Reiterated: Buy
Price Target: $14
Current: $8.25
Upside: +69.70%
Reiterated: Buy
Price Target: $13
Current: $3.30
Upside: +293.94%
Reiterated: Buy
Price Target: $24
Current: $11.85
Upside: +102.53%
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a
Reiterated: Buy
Price Target: $1.5
Current: $0.000001
Upside: n/a
Reiterated: Buy
Price Target: $96 → $15
Current: $0.36
Upside: n/a
Reiterated: Buy
Price Target: $3.5
Current: $1.66
Upside: n/a
Reiterated: Buy
Price Target: $60 → $50
Current: $25.13
Upside: n/a